About 45,000 prescriptions were written for sunosi (solriamfetol), a dual-acting dopamine and norepinephrine reuptake inhibitor indicated to improve wakefulness in adult patients with excessive daytime sleepiness due to narcolepsy or obstructive sleep apnea in the United States, … [Read more...]